# Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

> **NCT03699618** · — · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 1 (actual)

## Conditions studied

- Submacular Hemorrhage
- Wet Macular Degeneration
- Neovascular Age-related Macular Degeneration

## Interventions

- **DRUG:** Anti-VEGF
- **OTHER:** Hemorrhage displacement + Anti-VEGF

## Key facts

- **NCT ID:** NCT03699618
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-29
- **Primary completion:** 2020-01-06
- **Final completion:** 2020-01-06
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Challenging Enrollment
- **Last updated:** 2020-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03699618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03699618, "Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03699618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*